Joshua N Payette

Joshua N Payette is an accomplished inventor based in Lafayette, CO (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of chronic lymphocytic leukemia (CLL). His innovative work has led to the development of a patent that showcases his expertise and dedication to advancing medical science.

Latest Patents

Joshua N Payette holds a patent for "Pyrimidines for degrading Bruton's tyrosine kinase." This invention provides compounds of formula (I), wherein R, R, R, R, R, and R are defined, along with pharmaceutically acceptable salts. These compounds are useful as agents in the treatment of CLL, highlighting the potential impact of his work on patient care.

Career Highlights

Joshua is associated with AbbVie Inc., a leading biopharmaceutical company known for its commitment to innovation and improving patient outcomes. His role at AbbVie allows him to collaborate with other talented professionals in the field, further enhancing his contributions to medical research.

Collaborations

Some of his notable coworkers include Zhiguo Bian and Jason P Burke. Their collaboration fosters a dynamic environment for innovation and the development of new therapeutic solutions.

Conclusion

Joshua N Payette's work exemplifies the spirit of innovation in the pharmaceutical industry. His patent for pyrimidines demonstrates his commitment to improving treatments for chronic lymphocytic leukemia. Through his career at AbbVie Inc., he continues to make strides in medical research and development.

Profile summary based on public USPTO records.